Literature DB >> 1967946

Changes in resistance to mouth opening induced by depolarizing and non-depolarizing neuromuscular relaxants.

A F van der Spek1, P I Reynolds, W B Fang, J A Ashton-Miller, C S Stohler, M A Schork.   

Abstract

Mouth opening was measured in 43 children anaesthetized with isoflurane and paralysed with vecuronium or suxamethonium. Measurements of mouth opening were made for up to 10 min after loss of the adductor pollicis twitch and cessation of muscle fasciculations. In 22 patients receiving suxamethonium, a significant (P less than 0.001) reduction in mean mouth opening occurred in the 60 s after loss of twitch and cessation of fasciculations. Mouth opening reductions could last for up to 10 min after the loss of twitch, beyond the return of the twitch. One patient experienced "masseter spasm"; he did not develop malignant hyperpyrexia during 2.5 h of isoflurane anaesthesia. Patients receiving vecuronium showed a significant (P less than 0.0006) increase in mouth opening. In 20 subjects, mouth opening was generated with a small (1.67 N) and a larger (4.32 N) force. Proportionally equal reductions in mouth opening were obtained with either force after suxamethonium administration. Relatively equal increases with either force followed vecuronium administration. Isolated masseter spasm is not pathognomonic for malignant hyperpyrexia. If the diagnosis of malignant hyperpyrexia is contemplated, signs of hypermetabolism, such as increases in end-tidal carbon dioxide concentration during constant minute ventilation, should be sought.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967946     DOI: 10.1093/bja/64.1.21

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

Review 1.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 2.  Special article: Future directions in malignant hyperthermia research and patient care.

Authors:  Sharon J Hirshey Dirksen; Marilyn Green Larach; Henry Rosenberg; Barbara W Brandom; Jerome Parness; Robert Scott Lang; Meera Gangadharan; Tyler Pezalski
Journal:  Anesth Analg       Date:  2011-06-27       Impact factor: 5.108

Review 3.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 4.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 5.  The mouth-opening muscular performance in adults with and without temporomandibular disorders: A systematic review.

Authors:  Tzvika Greenbaum; Laurent Pitance; Ron Kedem; Alona Emodi-Perlman
Journal:  J Oral Rehabil       Date:  2022-01-31       Impact factor: 3.558

6.  Early Recognition and Treatment of Malignant Hyperthermia in Pediatric Patient during Bronchoscopy.

Authors:  Warangkana Lapisatepun; Supawan Arkarattanakul
Journal:  Case Rep Anesthesiol       Date:  2020-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.